GenerexBiotechnology @GenerexBiotech · 11m
Post# of 36519
![](/assets/46931549/no_avatar_available_thumb.jpg)
GenerexBiotechnology
@GenerexBiotech
·
11m
We are currently in ex-Vivo human studies for an Ii-Key #SARSCoV2vaccine using predictive algorithms and our proprietary Ii-Key technology platform to provide safe and long-lasting immunity from #COVID19. To learn more about this technology, visit http://Nugenerexio.com.
Came from the hub board.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)